Obstruction of CD96-CD155 interaction or TGF-β1 reestablishes NK cell immunity to tumors through reversing NK cell depletion, signifying a promising therapeutic role for CD96 in combating liver cancer (49). The gene discussed is CD96; the disease is liver cancer.